Overview Study of Motilitone to Treat Functional Dyspepsia Status: Completed Trial end date: 2018-02-01 Target enrollment: Participant gender: Summary This study is to evaluate efficacy of the investigational drug Motilitone at 90 mg in patients with Functional Dyspepsia as measured by change in maximum tolerated volume and aggregate symptom score on the nutrient drink test. Phase: Phase 2 Details Lead Sponsor: Dong-A ST Co., Ltd.